ISIN | IE00BWBXM617 |
---|---|
Valor Number | 28805622 |
Bloomberg Global ID | |
Fund Name | SPDR S&P U.S. Health Care Select Sector UCITS ETF USD |
Fund Provider |
State Street Global Advisors
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index. |
Peculiarities |
Current Price * | 44.10 USD | 02.04.2025 |
---|---|---|
Previous Price * | 43.82 USD | 01.04.2025 |
52 Week High * | 47.56 USD | 02.09.2024 |
52 Week Low * | 41.36 USD | 19.12.2024 |
NAV * | 44.10 USD | 02.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 370,179,187 | |
Unit/Share Assets *** | 370,179,186 | |
Trading Information SIX |
YTD Performance | +5.22% |
31.12.2024 - 02.04.2025
31.12.2024 02.04.2025 |
---|---|---|
YTD Performance (in CHF) | +2.41% |
31.12.2024 - 02.04.2025
31.12.2024 02.04.2025 |
1 month | -3.17% |
03.03.2025 - 02.04.2025
03.03.2025 02.04.2025 |
3 months | +5.21% |
02.01.2025 - 02.04.2025
02.01.2025 02.04.2025 |
6 months | -5.00% |
02.10.2024 - 02.04.2025
02.10.2024 02.04.2025 |
1 year | +1.41% |
02.04.2024 - 02.04.2025
02.04.2024 02.04.2025 |
2 years | +13.13% |
03.04.2023 - 02.04.2025
03.04.2023 02.04.2025 |
3 years | +9.57% |
04.04.2022 - 02.04.2025
04.04.2022 02.04.2025 |
5 years | +75.61% |
02.04.2020 - 02.04.2025
02.04.2020 02.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 13.31% | |
---|---|---|
UnitedHealth Group Inc | 8.02% | |
Johnson & Johnson | 7.29% | |
AbbVie Inc | 6.78% | |
Abbott Laboratories | 4.39% | |
Merck & Co Inc | 4.28% | |
Intuitive Surgical Inc | 3.74% | |
Thermo Fisher Scientific Inc | 3.71% | |
Amgen Inc | 3.04% | |
Boston Scientific Corp | 2.81% | |
Last data update | 28.02.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |